Alprolix
Jeneng umum: Coagulation Factor IX (Recombinant), Fc Fusion Protein
Bentuk dosis: bubuk lyophilized kanggo solusi kanggo injeksi intravena
Kelas obat:
Aneka modifikasi koagulasi
Panganggone Alprolix
Alprolix minangka obat suntik sing digunakake kanggo ngontrol lan nyegah getihen ing wong sing duwe hemofilia B. Hemofilia B uga diarani kekurangan Faktor IX bawaan.
Panyedhiya kesehatan sampeyan bisa menehi Alprolix nalika sampeyan kudu operasi.
Alprolix efek sisih
Efek samping sing umum kalebu nyeri sirah, sensasi ora normal ing tutuk, lan nyeri ing sisih sampeyan kanthi getih ing cipratan, sing bisa dadi tandha pembentukan bekuan ing sistem pengumpul urin.
Reaksi alergi bisa uga dumadi. Hubungi panyedhiya kesehatan utawa langsung njaluk perawatan darurat yen sampeyan duwe gejala ing ngisor iki: gatal-gatal, sesak dada, wheezing, angel ambegan, utawa bengkak ing pasuryan.
Abang ing kulit ing situs injeksi bisa uga kedadeyan.
Alprolix bisa nambah risiko pembentukan gumpalan getih sing ora normal ing awak, utamane yen sampeyan duwe faktor risiko ngembangake gumpalan getih. Telpon panyedhiya kesehatan utawa golek perawatan darurat yen sampeyan duwe gejala kemungkinan bekuan getih sing ora normal, sing bisa uga kalebu: nyeri dada, angel ambegan, bengkak sing ora dikarepake ing lengen utawa sikil kanthi utawa tanpa nyeri utawa nyeri.
Awak sampeyan uga bisa nggawe antibodi sing diarani "inhibitor" nglawan Alprolix, sing bisa nyegah Alprolix ora bisa digunakake kanthi bener. Panyedhiya kesehatan sampeyan bisa uga kudu nyoba getih kanggo inhibitor saka wektu kanggo wektu.
Iki ora kabeh efek samping sing bisa ditindakake.
Rembugan karo panyedhiya kesehatan babagan efek samping sing ngganggu. sampeyan utawa sing ora lunga.
Sadurunge njupuk Alprolix
Sampeyan ora kudu nggunakake Alprolix yen sampeyan alergi marang Alprolix utawa bahan liyane. Marang panyedhiya kesehatan yen sampeyan duwe reaksi alergi marang produk Factor IX sadurunge nggunakake Alprolix.
Related obat
- Advate
- Adynovate
- Adynovate recombinant
- Afstyla
- Afstyla recombinant
- Agrylin
- Alphanate
- Alphanine SD
- Alprolix
- Alprolix (Factor ix fc fusion protein recombinant Intravenous)
- Altuviiio
- Altuviiio (Antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl Intravenous)
- Altuviiio (Antihemophilic factor Intravenous)
- Amicar
- Amicar (Aminocaproic acid Intravenous)
- Amicar (Aminocaproic acid Oral)
- Aminocaproic acid
- Aminocaproic acid (Intravenous)
- Aminocaproic acid (Oral)
- Anagrelide
- Anti-inhibitor coagulant complex
- Antihemophilic and von Willebrand factor complex
- Antihemophilic factor
- Antihemophilic factor (recombinant) pegylated-aucl
- Antihemophilic factor (recombinant) porcine sequence
- Antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl
- Antihemophilic factor (recombinant), glycopegylated-exei
- Antihemophilic factor human
- Antihemophilic factor recombinant
- Antihemophilic factor viii and von willebrand factor
- Artiss
- Artiss Duo Set
- Artiss Duploject
- Autoplex T
- Coagadex
- Coagulation factor IX
- Coagulation factor ix recombinant
- Coagulation factor ix recombinant, glycopegylated
- Coagulation factor viia
- Coagulation factor VIIa injection
- Coagulation factor viia-jncw
- Coagulation factor X
- Corifact
- Cyklokapron
- Bebulin VH
- BeneFIX
- Benefix (Coagulation factor ix recombinant Intravenous)
- Ceprotin
- Defibrotide
- Defitelio
- Eloctate
- Eloctate with Fc Fusion Protein recombinant
- Emicizumab
- Emicizumab-kxwh
- Esperoct (Antihemophilic factor (recombinant), glycopegylated-exei Intravenous)
- Esperoct (Antihemophilic factor Intravenous)
- Esperoct recombinant
- Evarrest
- Factor ix albumin fusion protein recombinant
- Factor IX complex
- Factor ix fc fusion protein recombinant
- Factor x human
- Factor XIII
- Feiba VH Immuno
- Feiba-VH
- Fibrin sealant topical
- Fibrinogen
- Fibrinogen and thrombin, human
- Fibrinogen/aprotinin and thrombin/calcium chloride
- Fostamatinib
- Fostamatinib disodium
- Helixate FS
- Helixate FS recombinant
- Hemlibra
- Hemofil-M
- Hemofil-M human
- Humate-P
- Hyate:C
- Idelvion
- Idelvion (Factor ix albumin fusion protein recombinant Intravenous)
- Ixinity
- Ixinity (Coagulation factor ix recombinant Intravenous)
- Jivi (Antihemophilic factor (recombinant) pegylated-aucl Intravenous)
- Jivi (Antihemophilic factor Intravenous)
- Jivi recombinant
- Koate DVI
- Koate-DVI human
- Kogenate FS
- Kogenate FS recombinant
- Kogenate FS with Adapter recombinant
- Kovaltry recombinant
- Lysteda
- Monoclate-P human
- Mononine
- Novoeight recombinant
- Novoseven
- NovoSeven RT
- NovoSeven RT with MixPro injection
- Nuwiq recombinant
- Obizur (Antihemophilic factor (recombinant) porcine sequence Intravenous)
- Obizur (Antihemophilic factor Intravenous)
- Pentopak
- Pentoxifylline
- Pentoxil
- Protein c, human
- Raplixa
- Rebinyn
- Rebinyn (Coagulation factor ix recombinant, glycopegylated Intravenous)
- Recombinate recombinant
- RiaSTAP
- Rixubis
- Rixubis (Coagulation factor ix recombinant Intravenous)
- Roctavian
- Tachosil
- Tavalisse
- Thrombin human, recombinant
- Tisseel
- Tisseel Duploject Kit
- Tisseel Valupak Kit
- Tranexamic acid
- Tranexamic acid (Intravenous)
- Tranexamic acid (Oral)
- Tranexamic acid Lysteda
- Trental
- Tretten
- Valoctocogene roxaparvovec-rvox
- Von Willebrand factor recombinant
- Vonvendi
- Wilate
- Xyntha
Carane nggunakake Alprolix
Pengobatan lan kontrol episode pendarahan sing dikarepake:
Dosis Awal: Jinis Perdarahan Target Circulating FIX (IU/dL) Interval Dosis (jam) Minor lan Moderate 30-60 Baleni saben 48 jam yen perlu yen ana bukti getihen maneh. Utama 80-100 Coba dosis ulang sawise 6-10 jam, banjur saben 24 jam kanggo 3 dina, banjur saben 48 jam nganti waras.Manajemen perioperatif:
Profilaksis rutin:
Kanggo wong diwasa lan remaja ≥12 taun, diwiwiti kanthi 50 IU/kg sapisan saben minggu utawa 100 IU/kg sapisan saben 10 dina. Kanggo bocah-bocah <12 taun, diwiwiti kanthi 60 IU / kg sapisan saben minggu. Nyetel regimen dosis adhedhasar respon individu. Dosis sing luwih kerep utawa luwih dhuwur bisa uga dibutuhake ing bocah-bocah <12 taun.
Gunakake: dewasa lan bocah-bocah hemofilia B kanggo:
Apa obatan liyane bakal mengaruhi Alprolix
Marang panyedhiya kesehatan babagan kabeh obat sing sampeyan gunakake, kalebu kabeh obat resep lan non-resep, kayata obat-obatan, suplemen, utawa obat-obatan herbal.
Ora ana sing dingerteni. interaksi obat karo Alprolix.
Disclaimer
Kabeh upaya wis ditindakake kanggo mesthekake yen informasi sing diwenehake dening Drugslib.com akurat, nganti -tanggal, lan lengkap, nanging ora njamin kanggo efek sing. Informasi obat sing ana ing kene bisa uga sensitif wektu. Informasi Drugslib.com wis diklumpukake kanggo digunakake dening praktisi kesehatan lan konsumen ing Amerika Serikat lan mulane Drugslib.com ora njamin sing nggunakake njaba Amerika Serikat cocok, kajaba khusus dituduhake digunakake. Informasi obat Drugslib.com ora nyetujoni obat, diagnosa pasien utawa menehi rekomendasi terapi. Informasi obat Drugslib.com minangka sumber informasi sing dirancang kanggo mbantu praktisi kesehatan sing dilisensi kanggo ngrawat pasien lan / utawa nglayani konsumen sing ndeleng layanan iki minangka tambahan, lan dudu pengganti, keahlian, katrampilan, kawruh lan pertimbangan babagan perawatan kesehatan. praktisi.
Ora ana bebaya kanggo kombinasi obat utawa obat sing diwenehake kanthi cara apa wae kudu ditafsirake kanggo nuduhake yen obat utawa kombinasi obat kasebut aman, efektif utawa cocok kanggo pasien tartamtu. Drugslib.com ora nanggung tanggung jawab kanggo aspek kesehatan apa wae sing ditindakake kanthi bantuan informasi sing diwenehake Drugslib.com. Informasi sing ana ing kene ora dimaksudake kanggo nyakup kabeh panggunaan, pituduh, pancegahan, bebaya, interaksi obat, reaksi alergi, utawa efek samping. Yen sampeyan duwe pitakon babagan obat sing sampeyan gunakake, takon dhokter, perawat utawa apoteker.
Tembung kunci populer
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions